BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24299125)

  • 1. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.
    Bertoldi AD; Kanavos P; França GV; Carraro A; Tejada CA; Hallal PC; Ferrario A; Schmidt MI
    Global Health; 2013 Dec; 9():62. PubMed ID: 24299125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
    Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
    BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil.
    Nilson EAF; Metlzer AB; Labonté ME; Jaime PC
    PLoS One; 2020; 15(7):e0235514. PubMed ID: 32645031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country-a simulation of the current situation in Brazil.
    Rezende KF; Ferraz MB; Malerbi DA; Melo NH; Nunes MP; Pedrosa HC; Chacra AR
    Diabet Med; 2010 Jan; 27(1):109-12. PubMed ID: 20121897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study.
    Martins RB; Ordaz-Briseño SA; Flores-Hernández S; Bós ÂJG; Baptista-Rosas RC; Mercado-Sesma AR
    BMC Endocr Disord; 2021 Mar; 21(1):48. PubMed ID: 33726717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications.
    Lamri L; Gripiotis E; Ferrario A
    Global Health; 2014 Feb; 10():11. PubMed ID: 24564974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and Indirect Costs of Diabetes in Brazil in 2016.
    Pereda P; Boarati V; Guidetti B; Duran AC
    Ann Glob Health; 2022; 88(1):14. PubMed ID: 35340368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in diabetes management in Indonesia: a literature review.
    Soewondo P; Ferrario A; Tahapary DL
    Global Health; 2013 Dec; 9():63. PubMed ID: 24299164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-communicable chronic diseases in Brazil: from risk factors to social impact].
    Lessa I; Mendonça GA; Teixeira MT
    Bol Oficina Sanit Panam; 1996 May; 120(5):389-413. PubMed ID: 8924219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of noncommunicable diseases and implementation challenges of National NCD Programmes in India.
    Thakur JS; Paika R; Singh S
    Med J Armed Forces India; 2020 Jul; 76(3):261-267. PubMed ID: 32773927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.